Skip to main content

Table 2 Recurrence site correlated with initial treatment, histology, and FIGO stage

From: Reassessment of intensive surveillance practices adopted for endometrial cancer survivors

 

Local

Regional LN

Peritoneal dissemination

Distant metastasis

p-value*

Initial treatment

    

0.606

 ATH + BSO

1

4

4

10

 

 ATH + BSO + PLA

9

3

5

14

 

 ATH + BSO + PLA biopsy

3

2

2

5

 

 ATH + BSO + PLA + PAN

4

2

2

14

 

 NAC + ATH

0

2

0

2

 

Histology

    

0.098

 Endometrioid G1/G2

13

10

7

22

 

 Endometrioid G3

3

1

1

10

 

 serous

0

1

2

2

 

 others

1

1

3

11

 

FIGO Stage

    

0.650

 I

7

3

7

13

 

 II

1

1

0

2

 

 III

8

7

4

19

 

 IV

1

2

2

11

 
  1. ATH: abdominal hysterectomy; BSO: bilateral salpingo oophorectomy; PLA: pelvic lymph adenectomy; PAN: para-aortic lymphadenectomy; NAC: neoadjuvant chemotherapy; LN: lymphnode
  2. *Chi-square test was used
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us